Jagsonpal-Pharmaceuticals (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces the live activities schedule for the Offer to Buy (Buyback) acquisition window for Jagsonpal Pharmaceuticals Ltd, running from … | |||||||||||||||
BSE announces the live activities schedule for the Offer to Buy (Buyback) acquisition window for Jagsonpal Pharmaceuticals Ltd, running from 8th May 2026 to 14th May 2026, with an offer price of Rs. 250 per share for up to 16,00,000 equity shares.
| |||||||||||||||
BSE announces the opening of a tender offer buyback window for Jagsonpal Pharmaceuticals Limited, offering to repurchase up to 16,00,000 … | |||||||||||||||
BSE announces the opening of a tender offer buyback window for Jagsonpal Pharmaceuticals Limited, offering to repurchase up to 16,00,000 equity shares at Rs.250 per share for an aggregate consideration not exceeding Rs.40 crores.
| |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with … | |||||||||||||||
BSE/ICCL announces the settlement calendar for the Offer to Buy – Acquisition Window (Buyback) for Jagsonpal Pharmaceuticals Limited, with bidding open from May 8 to May 14, 2026 and settlement on May 21, 2026.
| |||||||||||||||